Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Zoster Vaccine in Young Adult Solid Organ Transplant Recipients
NCT06162494Phase 4Enrolling by invitation
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Start
- Mar 2024
- Primary completion
- Mar 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Zoster vaccine recombinant in varicella zoster virus infection, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Started Mar 2024; status: enrolling by invitation.
02
Drugs
Zoster vaccine recombinant
03
Conditions
varicella zoster virus infection
Beyond the preview
Go deeper on NCT06162494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06162494.